Real-World Treatment Patterns and Effectiveness in Patients with ALK plus Advanced NSCLC Treated with 1L ALK TKIs

被引：0
|
作者：
Chen, Y. [1 ]
Lin, H. M. [2 ]
Wan, Y. [2 ]
Yin, Y. [2 ]
Wu, Y. [2 ]
Hernandez, L. [3 ]
Danes, C. [3 ]
Churchill, E. N. [3 ]
Dimou, A. [4 ]
机构：
[1] Canc & Hematol Ctr, Grand Rapids, MI USA
[2] Takeda Dev Ctr Amer Inc, Lexington, MA USA
[3] Takeda Pharmaceut USA Inc, Lexington, MA USA
[4] Mayo Clin, Coll Med, Rochester, MN USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Brigatinib; Real-world data; ALK plus NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.12B.02
引用
收藏
页码：S641 / S641
页数：1
相关论文
共 50 条
  • [1] Real-World Outcomes of 2L ALK TKIs Following 1L Brigatinib for Patients with ALK plus NSCLC from the ALTA-1L Trial
    Ahn, M. -J.
    Delmonte, A.
    Ghosh, S.
    Hochmair, M.
    Yang, T. -Y.
    Yang, J. C. -H.
    Han, J. -Y.
    Hansen, K. Holmskov
    Wu, Y.
    Wan, Y.
    Lin, H. M.
    Kretz, J.
    Hupf, B.
    Kurec, A. M.
    Churchill, E. N.
    Fram, R. J.
    Cabasag, C. J.
    Goriya, V.
    Zhao, Y.
    Gemmen, E.
    Campelo, M. R. Garcia
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S200 - S200
  • [2] Real-World Clinically-Relevant Toxicities of ALK TKIs in a Cohort of Patients With Advanced/Metastatic ALK plus NSCLC
    Schmid, S.
    Chotai, S.
    Cheng, S.
    Zhan, L.
    Balaratnam, K.
    Khan, K.
    Patel, D.
    Brown, M. C.
    Xu, W.
    Moriarty, P.
    Kaidanovich-Beilin, O.
    Shepherd, F. A.
    Sacher, A.
    Leighl, N.
    Bradbury, P.
    Liu, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1088 - S1088
  • [3] Real-World Sequencing of ALK-TKIs in Advanced Stage ALK-positive NSCLC patients in Canada
    Chotai, S.
    Schmid, S.
    Cheng, S.
    Zhan, L.
    Balaratnam, K.
    Khan, K.
    Patel, D.
    Brown, M. C.
    Xu, W.
    Moriarty, P.
    Kaidanovich-Beilin, O.
    Shepherd, F. A.
    Sacher, A.
    Leighl, N.
    Bradbury, P.
    Liu, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1089 - S1089
  • [4] Real-World Patient Characteristics, Testing and Treatment Patterns of ALK plus NSCLC
    Gubens, M.
    Wong, W.
    Wu, N.
    Chu, L.
    Schulze, K.
    Illei, P.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1894 - S1895
  • [5] Real-world data on treatment patterns and survival among ALK plus NSCLC patients in Japan
    Nosaki, Kaname
    Toyozawa, Ryo
    Taguchi, Kenichi
    Edagawa, Makoto
    Shimamatsu, Shin-Ichiro
    Toyokawa, Goji
    Hirai, Fumihiko
    Yamaguchi, Masafumi
    Takeda, Yoko
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Real-World Treatment Patterns and Outcomes Across Three Lines of Therapy in Patients with ALK plus NSCLC
    Arnaoutakis, Konstantinos
    Wan, Yin
    Elliott, Jennifer
    Young, Matt
    Yin, Yu
    Leventakos, Konstantinos
    Lin, Huamao M.
    Dimou, Anastasios
    ADVANCES IN THERAPY, 2024, 41 (08) : 3217 - 3231
  • [7] Real-world comparative effectiveness of 1L alectinib (ALC) vs crizotinib (CRZ) in patients (pts) with ALK plus advanced NSCLC with or without baseline CNS metastases (mets)
    Krebs, M. G.
    Lin, J. J.
    Pal, N.
    Polito, L.
    Trinh, H. T. L.
    Hilton, M. M. S. M.
    Smoljanovic, V.
    Kurtsikidze, N.
    Archer, V.
    Zhang, Q.
    ANNALS OF ONCOLOGY, 2021, 32 : S959 - S959
  • [8] Real-World Treatment Patterns and Impact of Comorbidity Burden on Treatment Duration for Patients with ALK plus NSCLC in the US
    Wan, Y.
    Ren, K.
    Lin, H. M.
    Wu, Y.
    Humphries, M. J.
    Zhang, P.
    Jahanzeb, M.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S478 - S479
  • [9] Real-world data on treatment patterns and survival among ALK plus NSCLC patients in Japan. Treatment patterns and survival among ALK plus NSCLC patients in Japan: Single institute experience
    Seto, T.
    Nosaki, K.
    Toyozawa, R.
    Taguchi, K.
    Edagawa, M.
    Shimamatsu, S.
    Toyokawa, G.
    Hirai, F.
    Yamaguchi, M.
    Takeda, Y.
    Takenoyama, M.
    Ichinose, Y.
    ANNALS OF ONCOLOGY, 2017, 28
  • [10] Real-world ALK Testing Trends and Patterns in Patients with Advanced NSCLC in the United States
    Lin, H.
    Wu, Y.
    Yin, Y.
    Niu, H.
    Humphries, M.
    Lovly, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S210 - S210
12345